An analyst wrote two weeks ago that Protalix will not dilute. Last week it did and its price collapsed. I should invest more time in thinking by myself.
The manufacturing process of bioenzimes is very difficult. Genzyme, protalix's competitor, had to close its Allston plant for viral contamination. Dividends went fayfen.
No comments:
Post a Comment